£14.0M
The funding round was led by o2h Ventures Therapeutics Fund and supported by existing backers.
"We are pleased to welcome both o2h Ventures Therapeutics Fund as a new shareholder and Sunil Shah, Managing Partner of o2h Ventures Ltd as an observer on the Metrion board."